Jisun HJ Lee and Jiangjiang Zhu discuss volatile organic compounds produced by the gut microbiome and their relationship with human health. They also examine volatilomics, a field of metabolomics dedicated to the detection and quantification of gut microbial volatile compounds to reveal their function in human health and metabolism.
Browsing: mass spectrometry
Rawi Ramautar Biomedical Microscale Analytics Leiden Academic Centre for Drug Research Leiden University, The Netherlands…
In this interview, Chris Zhu (The Ohio State University) discusses what mass spectrometry-based volatilomics techniques currently exist and how these can be used to analyze biological samples.
A team from Martin Luther University Halle-Wittenberg (MLU; Halle, Germany) have developed a mass spectrometry method reportedly successful at detecting minute quantities of SARS-CoV-2 in patient gargle solutions. This method could potentially assist existing COVID-19 diagnostic tests.
In this interview, Ann Van Eeckhaut (Vrije Universiteit Brussel, Belgium) discusses her current focus in metabolomics research and the challenges her research group are currently facing.
In this interview, Timothy Garrett (University of Florida, FL, USA) discusses the use of MS in his research, some of the key differences between imaging MS and LC–MS and gives some top tips for method development.
Avacta (Cambridge, UK) has announced that the bead-assisted mass spectrometry test for COVID-19, currently in development with Adeptrix (MA, USA), has reached prototype stage.
High-resolution mass spectrometry has come a long way since its inception. As the field continues to evolve, take a look at the applications of HRMS. From exact mass to routine analyses, what’s next?
The use of atmospheric pressure ionization MS in biomarker detection is still in its infancy and extensive research and validation of methods would be required to ensure the development of robust, reproducible methods. In this editorial the use of API technology is discussed as it could truly revolutionize biomarker discovery and point-of-care measurements.